Spire Wealth Management - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$872
-64.3%
1310.0%0.00%
Q1 2023$2,444
+81366.7%
1310.0%0.00%
Q4 2022$3
-99.8%
1310.0%0.00%
Q3 2022$2,0000.0%1310.0%0.00%
Q2 2022$2,000
-33.3%
1310.0%0.00%
Q1 2022$3,0000.0%1310.0%0.00%
Q4 2021$3,000
-25.0%
1310.0%0.00%
Q3 2021$4,0000.0%1310.0%0.00%
Q2 2021$4,0001310.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 15,040$177,772,0000.69%
AlphaCentric Advisors LLC 50,000$591,0000.61%
Artemis Investment Management LLP 1,374,496$16,260,0000.18%
Knoll Capital Management, LLC 20,000$236,0000.14%
Game Plan Financial Advisors, LLC 11,280$133,0000.11%
Virtus ETF Advisers LLC 11,365$134,0000.05%
AllSquare Wealth Management LLC 5,527$65,0000.05%
Hennion & Walsh Asset Management, Inc. 34,231$405,0000.03%
Aquatic Capital Management LLC 10,000$118,0000.01%
Jump Financial, LLC 26,000$307,0000.01%
View complete list of BIOXCEL THERAPEUTICS INC shareholders